Bioabsorbable Orthopedic Implants Market Report 2026

The bioabsorbable orthopedic implants market size has grown rapidly in recent years. It will grow from $1.29 billion in 2025 to $1.46 billion in 2026 at a compound annual growth rate (CAGR) of 13.1%. The growth in the historic period can be attributed to increasing use of metallic implants for fracture fixation leading to demand for removal surgeries, rising incidence of sports injuries and trauma cases requiring orthopedic interventions, early development of biocompatible polymer materials for medical applications, growing clinical preference for minimally invasive surgical techniques, expansion of hospital infrastructure supporting orthopedic procedures.

The bioabsorbable orthopedic implants market size is expected to see rapid growth in the next few years. It will grow to $2.41 billion by 2030 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to rising adoption of biodegradable materials reducing secondary implant removal surgeries, increasing demand for patient specific orthopedic solutions using 3d printing, growing focus on faster recovery and reduced post surgical complications, advancement in biomaterial science enabling controlled degradation rates, expanding geriatric population increasing orthopedic treatment needs. Major trends in the forecast period include bioresorbable polymer innovation for next generation orthopedic fixation devices, personalized implant design using patient specific anatomical modeling, advanced composite material development for improved mechanical strength and degradation control, minimally invasive orthopedic procedures driving demand for absorbable fixation systems, smart biodegradable implants with controlled drug elution for enhanced bone healing.

The increasing incidence of orthopedic injuries is expected to propel the growth of the bioabsorbable orthopedic implants market going forward. Orthopedic injuries are damage to the musculoskeletal system, including bones, joints, ligaments, tendons, and muscles, often caused by trauma, sports activities, accidents, or age-related conditions. The rising incidence of orthopedic injuries is driven by increasing participation in sports and physical activities, a growing aging population, and a higher risk of road accidents and trauma cases. Bioabsorbable orthopedic implants support orthopedic care by providing temporary structural support for bone healing while naturally degrading within the body, eliminating the need for surgical removal, enhancing treatment efficiency, and improving patient care outcomes. For instance, in 2024, according to the Consumer Product Safety Commission, sports and recreational injuries treated in emergency departments increased by 17% compared to 2023, continuing a rising trend after the pandemic-related decline, with total cases reaching approximately 4.4 million in 2024. Therefore, the increasing incidence of orthopedic injuries is contributing to and propelling the growth of the bioabsorbable orthopedic implants market.

Leading companies operating in the bioabsorbable orthopedic implants market are focusing on advancements in magnesium-based bioabsorbable implants, such as magnesium alloy-based fixation devices, to meet the rising demand for faster bone healing, minimally invasive procedures, and the elimination of secondary implant removal surgeries. Magnesium-based bioabsorbable implants are advanced orthopedic devices composed of biodegradable metal alloys that offer mechanical strength comparable to traditional titanium implants while gradually degrading in the body, supporting natural bone regeneration and reducing long-term complications associated with permanent implants. For example, in June 2024, Bioretec Ltd., a Finland-based medical device company, launched the RemeOs trauma screw. The implant is made from a proprietary magnesium alloy designed to provide high mechanical strength along with controlled biodegradation. It enables stable fracture fixation while gradually resorbing in sync with the bone healing process, eliminating the need for implant removal surgery. Additionally, the screw promotes bone growth through its biological interaction with surrounding tissue and is suitable for applications such as trauma surgery, osteotomies, and deformity correction.

In January 2025, Zimmer Biomet Holdings, Inc. acquired Paragon 28, Inc. for $1.1 billion. Through this acquisition, Zimmer Biomet intends to strengthen its foot and ankle portfolio and broaden its presence in the rapidly growing extremities segment by leveraging Paragon 28’s specialized product offerings and innovation capabilities. Paragon 28, Inc. is a US-based orthopedic company with a strong focus on developing and commercializing implants and surgical instruments specifically designed for foot and ankle procedures.

Major companies operating in the bioabsorbable orthopedic implants market are Johnson & Johnson Services Inc., Stryker Corporation, Evonik Industries AG, B. Braun SE, Zimmer Biomet Holdings Inc., Teijin Limited, Smith & Nephew plc, Arthrex Inc., Meril Life Sciences Pvt. Ltd., CONMED Corporation, Orthofix Medical Inc., Wright Medical Group N. V., KLS Martin Group (Gebrüder Martin GmbH & Co. KG), Cook Biotech Incorporated LLC, Anika Therapeutics Inc., Acumed LLC, OrthoPediatrics Corp., Xtant Medical Holdings Inc., Citieffe S. r. l., Biometrix Ltd., Bioretec Ltd., Orthomed S. A. S., Aziyo Biologics Inc.

North America was the largest region in the bioabsorbable orthopedic implants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioabsorbable orthopedic implants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the bioabsorbable orthopedic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioabsorbable orthopedic implants market consists of sales of screws, pins, plates, rods, and other fixation devices, including polymer-based, composite-based, and magnesium-based implants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.